$CLRB Cellectar Biosciences, Inc. Insiders

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Cellectar Biosciences, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of current and past insiders in Cellectar Biosciences, Inc.. Find out how many shares they currently own, their value and whether they buy or sell their shares.

Cellectar Biosciences, Inc. Insiders

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
AWM Investment Company, Inc.10% Owner702,5621,173,279Jan 04 2016
BERNS PAUL LDirector117,371196,010shares bought: 117,371 / shares sold: 0 BUYApr 21 2016
CARUSO JAMES VPresident and CEO86,401144,290shares bought: 411,825 / shares sold: -34,000 STRONG BUYMar 05 202118 months ago
DRISCOLL FREDERICK WDirector00Jun 25 2020
Elefant DovChief Financial Officer11,75519,631shares bought: 21,755 / shares sold: 0 STRONG BUYMar 05 202118 months ago
Friend John E. IIChief Medical Officer100,000167,000shares bought: 100,000 / shares sold: 0 BUYMar 05 202118 months ago
Genn John PatrickVP of Business Development00Mar 04 2015
Grachev Igor DChief Medical Officer00Jan 08 2020
Hertzberg Richard280,000467,600shares bought: 238,500 / shares sold: -21,000 STRONG BUYNov 01 2016
HILL STEPHEN ADirector18,00030,060shares bought: 27,390 / shares sold: -992 STRONG BUYJun 25 2020
HILL STEPHEN ADirector5,3008,851Aug 22 2014
Kolean Chad JVP, Chief Financial Officer80,000133,600shares bought: 80,000 / shares sold: 0 BUYApr 20 2017
Longcor JarrodChief Business Officer102,148170,587shares bought: 215,448 / shares sold: -13,000 STRONG BUYMar 05 202118 months ago
Loren StefanDirector00Jun 25 2020
MARXE AUSTIN W & GREENHOUSE DAVID M10% Owner1,142,3681,907,755Sep 10 2014
NEIS JOHNDirector626,1031,045,592shares bought: 568,075 / shares sold: -5,214 STRONG BUYMar 19 202117 months ago
NEIS JOHNDirector632,4261,056,151Aug 22 2014
Pedder SimonPresident and CEO13,30022,211Aug 22 2014
POSNER BRIAN MChief Financial Officer00Jan 18 2019
Swirsky Douglas JDirector00Jun 25 2020
Szakacs CameronVP of Clinical Development00Dec 18 2014
Weichert Jamey PChief Scientific Officer00May 23 2016